(19)
(11)
EP 4 815 979 A1
(12)
(43)
Date of publication:
07.10.2026
Bulletin 2026/41
(21)
Application number:
23960321.0
(22)
Date of filing:
30.11.2023
(51)
International Patent Classification (IPC):
A61K
38/51
(2006.01)
A61P
25/00
(2006.01)
A61P
9/10
(2006.01)
A61P
39/06
(2006.01)
(52)
Cooperative Patent Classification (CPC):
C12Y
402/01092
;
A61K
38/51
;
A61P
39/06
;
A61K
9/0043
(86)
International application number:
PCT/NZ2023/050141
(87)
International publication number:
WO 2025/116747
(
05.06.2025
Gazette 2025/23)
(84)
Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN
(71)
Applicant:
Lipoxagen Limited
4410 Palmerston North (NZ)
(72)
Inventors:
MACKAY, Sean
(NZ)
CLARKSON, Andrew
(NZ)
(74)
Representative:
Ström & Gulliksson AB
P.O. Box 4188
203 13 Malmö
203 13 Malmö (SE)
(54)
TREATMENT OF CENTRAL NERVOUS SYSTEM INJURY